Steven Cohen Sol Gel Technologies Ltd. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$6.2 - $7.8 $55,800 - $70,200	-9,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.5 - $10.71 $7,500 - $10,710	-1,000 Reduced 10.0%	9,000 $69,000
Q1 2018 May 15, 2018	BUY	$10.3 - $13.64 $103,000 - $136,400	10,000 New	10,000 $103,000

7.34M

5.4K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $15.3M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.